Newsletter December 2020

2020 has been a difficult year for everyone. However, despite the many…

Words Lucie van Leeuwen.Published January 5, 2021
Newsletter December 2020

2020 has been a difficult year for everyone. However, despite the many challenges, we can also look back on some milestone achievements. In our latest newsletter, we review some of our major highlights. Click the link to read our newsletter: http://bit.ly/3njT6nQ

Would you like to receive our next newsletter in your email? You can subscribe here: https://www.tricals.org/subscribe-to-our-newsletter/

We look forward to the new year in which we will undoubtedly achieve even more together. Together we will build our highway towards new therapies for ALS.


Share

Related news

Food and Drug Administration (FDA) approves AMX0035 (Amylyx) for the American market
Food and Drug Administration (FDA) approves AMX0035 (Amylyx) for the American market
During a meeting of the FDA’S Peripheral and Central Nervous System Drugs […]
Measuring treatment effects based on patient preference
Measuring treatment effects based on patient preference
To evaluate the effect of an investigational drug in ALS clinical trials, […]
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS (the Treatment Research Initiative to Cure ALS), in collaboration with ALS […]
USA: new law promises $100 million for ALS research
USA: new law promises $100 million for ALS research
A new law has been passed in the United States to give […]